MedPath

A study to determine the safety and efficacy of Autologous Human Platelet Lysate (HPL) in treatment of Facial Wrinkles (Nasolabial Folds).

Phase 1
Completed
Conditions
Health Condition 1: null- Facial Wrinkles (Nasolabial Folds)
Registration Number
CTRI/2012/05/002627
Lead Sponsor
KASIAK RESEARCH PRIVATE LIMITED
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

1.Subjects (male and female), aged 18 to 40 years (both inclusive).

2.Subjects willing to refrain from any other treatment for Nasolabial Folds.

3.Subjects who are willing to give informed consent and adhere to the study protocol.

Exclusion Criteria

1.Subjects receiving any aesthetic facial therapy 6 months prior to enrolment e.g. Botox, Fillers etc

2.Subjects with history of Connective tissue disease

3. Subjects with autoimmune diseases

4. Subjects unwilling to or unable to comply with the study protocol.

5.Subjects taking concomitant therapy that might interfere with the study results in the investigatorâ??s opinion or participating in another trial in the past 30days

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
â?¢Wrinkle Severity Rating Scale ( WSRS ) as per ATLAS photographic grading at rest <br/ ><br>â?¢Wrinkle Severity Rating Scale ( WSRS ) as per ATLAS photographic grading on full smile <br/ ><br>â?¢Global Aesthetic Improvement Scale (GAIS ) <br/ ><br>Timepoint: End of Study - 3 Months
Secondary Outcome Measures
NameTimeMethod
â?¢Photographic Assessment <br/ ><br>â?¢Physicianâ??s assessment scores <br/ ><br>â?¢Patientâ??s assessment scores <br/ ><br>Timepoint: End of Study - 3 Months
© Copyright 2025. All Rights Reserved by MedPath